Yahoo
LSE - Delayed Quote GBp

Spire Healthcare Group plc (SPI.L)

249.00 +0.50 (+0.20%)
At close: October 30 at 4:35:14 PM GMT
Chart Range Bar
Loading chart for SPI.L
  • Previous Close 248.50
  • Open 249.00
  • Bid 248.00 x --
  • Ask 248.50 x --
  • Day's Range 248.00 - 249.00
  • 52 Week Range 140.80 - 249.50
  • Volume 440,473
  • Avg. Volume 2,494,986
  • Market Cap (intraday) 997.488M
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) --
  • EPS (TTM) -0.00
  • Earnings Date Sep 30, 2026
  • Forward Dividend & Yield 0.02 (0.60%)
  • Ex-Dividend Date May 21, 2026
  • 1y Target Est 264.25

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

www.spirehealthcare.com

17,800

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

SPI.L
49.11%
FTSE 100 (^FTSE)
8.04%

1-Year Return

SPI.L
5.29%
FTSE 100 (^FTSE)
9.94%

3-Year Return

SPI.L
17.76%
FTSE 100 (^FTSE)
46.43%

5-Year Return

SPI.L
5.99%
FTSE 100 (^FTSE)
48.25%

Analyst Insights

View More

Analyst Price Targets

250.00
264.25 Average
249.00 Current
282.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 2/12/2019
Analyst Credit Suisse
Rating Action Downgrade
Rating Underperform
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.12%

  • Return on Assets (ttm)

    3.19%

  • Return on Equity (ttm)

    -0.18%

  • Revenue (ttm)

    1.58B

  • Net Income Avi to Common (ttm)

    -1.9M

  • Diluted EPS (ttm)

    -0.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.4M

  • Total Debt/Equity (mrq)

    179.84%

  • Levered Free Cash Flow (ttm)

    93.35M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: